23andMe Archives | the deep dive

the deep dive

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

23andMe

Drugmaker Regeneron Acquires 23andMe for $256M

Court Approves Sale of 23andMe DNA Data in Bankruptcy Proceedings

23AndMe: Bankruptcy Filing Leaves Genetic Data on the Auction Block

Texas Oilman Pitches To Buy 23andMe for $100 Million

23andMe’s Financial Freefall Sparks Fears Over Genetic Data Security

This 23andMe Referral Scam May Just Be The Best One of 2023

23andMe Scrambles to Change Terms to Avoid Lawsuits Following Massive Security Breach

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

NexGen Launches 42,000 Metre Drill Program At PCE While Expanding Mineralized Footprint

First Majestic Hits 2025 Guidance, Producing 31.1 Million Silver Equivalent Ounces, Increases Dividend